Revisiting the past

Intra-arterial vasopressin for severe gastrointestinal bleeding in Crohn's disease

Venkata (Mahesh) Alla, Vijayanadh Ojili, Janardhana Gorthi, Attila Csordas, Radha Krishna Yellapu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Technological advances in the last couple of decades have led to a tremendous improvement in the safety and efficacy of embolization making it the therapeutic intervention of choice in angiogram positive lower gastrointestinal bleeding. Vasopressin has thus been forgotten and it is hardly ever used by the current generation of interventionists. However, coil embolization is technically challenging and requires greater expertise. Difficulty in super-selective catheterization and lack of adequate collateralization can also prevent successful delivery of coils. In this article we present the successful use of intra-arterial vasopressin in a patient with Crohn's disease with severe lower gastrointestinal bleeding. Despite not being the first choice, vasopressin can be safely and effectively used in selected patients who are not candidates for embolotherapy. The purpose of this article is to discuss the relative merits and demerits of vasopressin vis-à-vis embolization and to identify the role of vasopressin in the current era of super-selective embolization. Successful control of massive lower gastrointestinal bleeding by intra-arterial vasopressin infusion has previously been reported only once before in Crohn's disease. We suggest that this technique may be used in an attempt to avoid surgery in these patients.

Original languageEnglish
Pages (from-to)479-482
Number of pages4
JournalJournal of Crohn's and Colitis
Volume4
Issue number4
DOIs
StatePublished - Oct 2010

Fingerprint

Vasopressins
Crohn Disease
Hemorrhage
Therapeutic Embolization
Intra Arterial Infusions
Catheterization
Angiography
Safety

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Revisiting the past : Intra-arterial vasopressin for severe gastrointestinal bleeding in Crohn's disease. / Alla, Venkata (Mahesh); Ojili, Vijayanadh; Gorthi, Janardhana; Csordas, Attila; Yellapu, Radha Krishna.

In: Journal of Crohn's and Colitis, Vol. 4, No. 4, 10.2010, p. 479-482.

Research output: Contribution to journalArticle

Alla, Venkata (Mahesh) ; Ojili, Vijayanadh ; Gorthi, Janardhana ; Csordas, Attila ; Yellapu, Radha Krishna. / Revisiting the past : Intra-arterial vasopressin for severe gastrointestinal bleeding in Crohn's disease. In: Journal of Crohn's and Colitis. 2010 ; Vol. 4, No. 4. pp. 479-482.
@article{2e18ec67bdc64fbdb9c6bc62e458e616,
title = "Revisiting the past: Intra-arterial vasopressin for severe gastrointestinal bleeding in Crohn's disease",
abstract = "Technological advances in the last couple of decades have led to a tremendous improvement in the safety and efficacy of embolization making it the therapeutic intervention of choice in angiogram positive lower gastrointestinal bleeding. Vasopressin has thus been forgotten and it is hardly ever used by the current generation of interventionists. However, coil embolization is technically challenging and requires greater expertise. Difficulty in super-selective catheterization and lack of adequate collateralization can also prevent successful delivery of coils. In this article we present the successful use of intra-arterial vasopressin in a patient with Crohn's disease with severe lower gastrointestinal bleeding. Despite not being the first choice, vasopressin can be safely and effectively used in selected patients who are not candidates for embolotherapy. The purpose of this article is to discuss the relative merits and demerits of vasopressin vis-{\`a}-vis embolization and to identify the role of vasopressin in the current era of super-selective embolization. Successful control of massive lower gastrointestinal bleeding by intra-arterial vasopressin infusion has previously been reported only once before in Crohn's disease. We suggest that this technique may be used in an attempt to avoid surgery in these patients.",
author = "Alla, {Venkata (Mahesh)} and Vijayanadh Ojili and Janardhana Gorthi and Attila Csordas and Yellapu, {Radha Krishna}",
year = "2010",
month = "10",
doi = "10.1016/j.crohns.2010.02.011",
language = "English",
volume = "4",
pages = "479--482",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Revisiting the past

T2 - Intra-arterial vasopressin for severe gastrointestinal bleeding in Crohn's disease

AU - Alla, Venkata (Mahesh)

AU - Ojili, Vijayanadh

AU - Gorthi, Janardhana

AU - Csordas, Attila

AU - Yellapu, Radha Krishna

PY - 2010/10

Y1 - 2010/10

N2 - Technological advances in the last couple of decades have led to a tremendous improvement in the safety and efficacy of embolization making it the therapeutic intervention of choice in angiogram positive lower gastrointestinal bleeding. Vasopressin has thus been forgotten and it is hardly ever used by the current generation of interventionists. However, coil embolization is technically challenging and requires greater expertise. Difficulty in super-selective catheterization and lack of adequate collateralization can also prevent successful delivery of coils. In this article we present the successful use of intra-arterial vasopressin in a patient with Crohn's disease with severe lower gastrointestinal bleeding. Despite not being the first choice, vasopressin can be safely and effectively used in selected patients who are not candidates for embolotherapy. The purpose of this article is to discuss the relative merits and demerits of vasopressin vis-à-vis embolization and to identify the role of vasopressin in the current era of super-selective embolization. Successful control of massive lower gastrointestinal bleeding by intra-arterial vasopressin infusion has previously been reported only once before in Crohn's disease. We suggest that this technique may be used in an attempt to avoid surgery in these patients.

AB - Technological advances in the last couple of decades have led to a tremendous improvement in the safety and efficacy of embolization making it the therapeutic intervention of choice in angiogram positive lower gastrointestinal bleeding. Vasopressin has thus been forgotten and it is hardly ever used by the current generation of interventionists. However, coil embolization is technically challenging and requires greater expertise. Difficulty in super-selective catheterization and lack of adequate collateralization can also prevent successful delivery of coils. In this article we present the successful use of intra-arterial vasopressin in a patient with Crohn's disease with severe lower gastrointestinal bleeding. Despite not being the first choice, vasopressin can be safely and effectively used in selected patients who are not candidates for embolotherapy. The purpose of this article is to discuss the relative merits and demerits of vasopressin vis-à-vis embolization and to identify the role of vasopressin in the current era of super-selective embolization. Successful control of massive lower gastrointestinal bleeding by intra-arterial vasopressin infusion has previously been reported only once before in Crohn's disease. We suggest that this technique may be used in an attempt to avoid surgery in these patients.

UR - http://www.scopus.com/inward/record.url?scp=77957306545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957306545&partnerID=8YFLogxK

U2 - 10.1016/j.crohns.2010.02.011

DO - 10.1016/j.crohns.2010.02.011

M3 - Article

VL - 4

SP - 479

EP - 482

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - 4

ER -